Raub Brock Capital Management LP Dexcom Inc Transaction History

Raub Brock Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$75.49 - $124.16 $177,778 - $292,396	2,355 New	2,355 $292,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $168,260 - $242,886	1,980 New	1,980 $224,000
Q2 2022 Jul 07, 2022	SELL	$67.99 - $132.89 $33,655 - $65,780	-495 Closed	0 $0
Q1 2022 Apr 13, 2022	SELL	$94.08 - $130.2 $18,816 - $26,039	-200 Reduced 28.78%	495 $253,000
Q4 2020 Jan 06, 2021	BUY	$78.0 - $104.5 $54,210 - $72,627	695 New	695 $257,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Raub Brock Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Raub Brock Capital Management LP with notifications on news.